Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.

Por Borre, M., Offersen, B. V., Nerstrøm, B., Overgaard, J.
Publicado em 1998

Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial

Por Jensen BT, Jensen JB, Laustsen S, Petersen AK, Søndergaard I, Borre M
Publicado em 2014-07-01

Survival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort study

Por Lund, Lars, Erichsen, R, Nørgaard, M, Larsen, E H, Borre, M, Jacobsen, J
Publicado em 2011

Evolution of the Borrelia burgdorferi outer surface protein OspC.

Por Theisen, M, Borre, M, Mathiesen, M J, Mikkelsen, B, Lebech, A M, Hansen, K
Publicado em 1995

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

Por Tørring, N, Borre, M, Sørensen, K D, Andersen, C L, Wiuf, C, Ørntoft, T F
Publicado em 2007

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

Por Dyrskjøt, L, Zieger, K, Kissow Lildal, T, Reinert, T, Gruselle, O, Coche, T, Borre, M, Ørntoft, T F
Publicado em 2012

Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children.

Por Dziegiel, M, Rowe, P, Bennett, S, Allen, S J, Olerup, O, Gottschau, A, Borre, M, Riley, E M
Publicado em 1993

Characterization of repetitive DNA in the Mycoplasma genitalium genome: possible role in the generation of antigenic variation.

Por Peterson, S N, Bailey, C C, Jensen, J S, Borre, M B, King, E S, Bott, K F, Hutchison, C A
Publicado em 1995

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer

Por Sørensen, K D, Abildgaard, M O, Haldrup, C, Ulhøi, B P, Kristensen, H, Strand, S, Parker, C, Høyer, S, Borre, M, Ørntoft, T F
Publicado em 2013

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

Por Villadsen, S B, Bramsen, J B, Ostenfeld, M S, Wiklund, E D, Fristrup, N, Gao, S, Hansen, T B, Jensen, T I, Borre, M, Ørntoft, T F, Dyrskjøt, L, Kjems, J
Publicado em 2012

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

Por Munksgaard, P P, Mansilla, F, Brems Eskildsen, A-S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, G G, Ørntoft, T F, Dyrskjøt, L
Publicado em 2011

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

Por Dyrskjøt, L, Reinert, T, Novoradovsky, A, Zuiverloon, T C M, Beukers, W, Zwarthoff, E, Malats, N, Real, F X, Segersten, U, Malmström, P-U, Knowles, M, Hurst, C, Sorge, J, Borre, M, Ørntoft, T F
Publicado em 2012

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

Por Teo, M. T. W., Dyrskjøt, L., Nsengimana, J., Buchwald, C., Snowden, H., Morgan, J., Jensen, J. B., Knowles, M. A., Taylor, G., Barrett, J. H., Borre, M., Ørntoft, T. F., Bishop, D. T., Kiltie, A. E.
Publicado em 2014